{"id":41543,"date":"2024-06-17T11:25:00","date_gmt":"2024-06-17T03:25:00","guid":{"rendered":"\/\/www.rdaar.com\/?p=41543"},"modified":"2024-09-05T11:52:26","modified_gmt":"2024-09-05T03:52:26","slug":"common-sleep-supplement-may-be-linked-to-lower-risk-of-vision-loss","status":"publish","type":"post","link":"\/\/www.rdaar.com\/en\/2024\/06\/17\/common-sleep-supplement-may-be-linked-to-lower-risk-of-vision-loss\/","title":{"rendered":"Common Sleep Supplement may be Linked to Lower Risk of Vision Loss"},"content":{"rendered":"\t\t
Melatonin – an over-the-counter supplement to help people sleep – may decrease the risks of age-related eyesight loss, a US study showed.<\/strong><\/p> The “sleep hormone” and common supplement melatonin could be linked to a decreased risk of age-related macular degeneration (AMD).<\/p> AMD is a progressive eye condition affecting the macula, a small area near the centre of the retina, and can blur your central vision.<\/p> There is no definitive cure for AMD but several treatments can help manage the condition and slow its progression.<\/p> A team of researchers from the Case Western Reserve University School of Medicine and the Cole Eye Institute both based in the US looked at the health data of over 200,000 people, some at an early stage of the disease and some without age-related eyesight issues.<\/p> They compared people who used melatonin supplements with those who didn’t in a peer-reviewed study published in JAMA Opthalmology<\/a><\/span>.<\/p> The researchers found that melatonin was associated with a reduced risk of age-related eyesight deterioration in individuals without any decline.<\/p> It was also linked to a lower risk of further loss of eyesight in those already experiencing it at an early stage.<\/p>